Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 28, 2018 12:01 ET | Source: PCI Synthesis; Novacap

Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.

LYON, France and NEWBURYPORT, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has completed the...
June 20, 2018 12:03 ET | Source: PCI Synthesis; Novacap

Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

LYON, France and NEWBURYPORT, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an...
February 27, 2018 09:15 ET | Source: PCI Synthesis

PCI Synthesis Celebrates Key Milestones Including 4th Consecutive Year of Double-Digit Growth, 2 Commercial Approvals and a New Office in San Diego

NEWBURYPORT, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEis), generic active pharmaceutical...
January 30, 2018 09:15 ET | Source: PCI Synthesis

PCI Synthesis Submits Patent for Synthesizing Azelaic Acid

NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
January 11, 2018 09:15 ET | Source: PCI Synthesis

PCI Synthesis’ Ed Price Joins SOCMA’s Board of Governors

NEWBURYPORT, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
December 18, 2017 09:15 ET | Source: PCI Synthesis

PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2018

NEWBURYPORT, Mass., Dec. 18, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
November 15, 2017 10:15 ET | Source: PCI Synthesis

Scott VanderWel Joins PCI Synthesis as Business Development Manager

NEWBURYPORT, Mass., Nov. 15, 2017 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical...
March 23, 2017 09:14 ET | Source: PCI Synthesis

PCI Synthesis Wins Big at 2017 Life Science Leader Magazine CMO Leadership Awards

NEWBURYPORT, MA--(Marketwired - Mar 23, 2017) - PCI Synthesis, Inc., a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other...
February 01, 2017 09:11 ET | Source: PCI Synthesis

PCI Synthesis picks up Life Science CMO Leaderships Awards in all six categories

NEWBURYPORT, MA--(Marketwired - Feb 1, 2017) - PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...
December 19, 2016 09:16 ET | Source: PCI Synthesis

PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2017

NEWBURYPORT, MA--(Marketwired - Dec 19, 2016) - PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients...

Next Page keyboard_arrow_right